Skip to main content
Equibles

Kathleen LaPorte

Board Member

Q32 Bio Inc. (QTTB)

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Kathleen LaPorte

Kathleen LaPorte is recorded as Board Member at Q32 Bio Inc. (QTTB). Kathleen LaPorte was last confirmed as Board Member at Cero Therapeutics Holdings, Inc. (CERO) in a filing dated April 15, 2024. Kathleen LaPorte was last confirmed as Board Member at Bolt Biotherapeutics, Inc. (BOLT) in a filing dated April 26, 2024. Q32 Bio Inc. reported in an 8-K filed March 27, 2024 that Kathleen LaPorte was appointed Class II director, effective March 25, 2024. Cero Therapeutics Holdings, Inc. reported in an 8-K filed February 15, 2024 that Kathleen LaPorte was appointed director of the Company.

“Dr. Tzianabos, Ms. Morrison and Ms. LaPorte were appointed as Class II directors (terms expire at our 2026 annual meeting)”
Q32 Bio Inc. Form 8-K, filed March 27, 2024 · Read the filing
“Mr. Byrnes, Mr. Atwood, Ms. LaPorte, Mr. Corey and Mr. Ehrlich were appointed as directors of the Company, to serve until the end of their respective terms and until their successors are elected and qualified.”
Cero Therapeutics Holdings, Inc. Form 8-K, filed February 15, 2024 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Q32 Bio Inc.

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.